Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd maintains a conservative capital structure with a price-to-book ratio of 0.8 and a debt-to-equity ratio of 0.0, indicating minimal leverage. The company's liquidity position is strong, with a current ratio of 1.3 and cash and equivalents of 143.1 million CNY, which supports operational flexibility. The market capitalization of 1.34 billion CNY and a price-to-earnings ratio of 6.76 suggest the stock is trading at a discount relative to earnings. The company's profitability is robust, with a return on equity of 11.78% and a return on assets of 7.45%, both exceeding the typical thresholds for the pharmaceutical industry. Gross profit of 757.67 million CNY and operating income of 265.85 million CNY reflect strong cost control and pricing power. However, the net income of 198.88 million CNY is lower than the gross profit, indicating some pressure on operating expenses or taxes. Geographic and segment exposure data is not available in the provided input, but the company's revenue of 901.87 million CNY is likely concentrated in its domestic operations given the lack of international revenue breakdown. The absence of detailed segment reporting limits the ability to assess diversification or growth drivers within the business. The company's growth trajectory is modest, with no specific revenue or earnings growth projections provided in the input data. Analyst estimates for the last actual EPS and revenue are 0.02 CNY and 97.28 million CNY, respectively, which are slightly below the reported figures, suggesting a stable but not rapidly growing business. The free cash flow of 96.17 million CNY and capital expenditure of -12.45 million CNY indicate that the company is generating positive cash flow and may be reducing investments in physical assets. Risk factors for the company are minimal, with low liquidity and dilution risks identified. No immediate filing-based liquidity or dilution flags were detected, and the company's capital structure remains stable. The absence of significant debt and the presence of substantial cash reserves reduce the likelihood of financial distress. Recent events and filings do not show any material changes in the company's operations or financial condition. The lack of recent significant events or disclosures suggests a stable and predictable business environment. The company's financial performance and risk profile remain consistent with its historical trends.